He affirmed that the new drug "could take the epidemic to the history books," according to Mother Jones.Yeztugo, based on the molecule lenacapavir, offers a more effective and less invasive prevention method,

A new HIV prevention shot, approved by the FDA and taken just twice a year, could transform global care, but experts warn shrinking health budgets may limit access in high-risk areas.

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming infected with HIV. But big questions remain over the drug’s affordability.